Press Releases - Emmaus Medical, Inc.

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business UpdateMay 15, 2023

Emmaus Life Sciences, Inc. today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023.

Emmaus Life Sciences Provides Interim Shipment DataApril 03, 2023

Emmaus announced today preliminary results for the 3 months that ended March 31, 2023.

Emmaus Life Sciences Reports 2022 Financial Results and Provides Business UpdateMarch 31, 2023

Emmaus Life Sciences, Inc. (OTCQX: EMMA), today reported its results of operation for the year ended December 31, 2022 and an update on recent activities.

Dr. Niihara Meets with Local Indian GovernorDecember 20, 2022

Cites Large, Unserved Needs of Sickle Cell Disease Patient

Dr. Niihara Feted by Indian Government in Recognition of the Development of EndariDecember 19, 2022

Emmaus Life Sciences, Inc. announced today that Dr. Yutaka Niihara, Chairman and Chief Executive Officer of the company, was feted at an event held on December 16, 2022 at the World Trade Center in Mumbai, India by the Minister of State of India, Arun Halder, in recognition of Dr. Niihara’s work in developing Endari to treat sickle cell disease (SCD).